Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Harpoon Therapeutics Inc (HARP)

  7. Harpoon Therapeutics Inc (HARP) News

HARP

Harpoon Therapeutics Inc

0.6797
-0.009 (-1.31%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Harpoon Therapeutics Inc HARP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.009 -1.31% 0.6797 17:09:52
Open Price Low Price High Price Close Price Prev Close
0.6742 0.6741 0.70 0.68 0.6887
more quote information »

Recent News

Date Time Source Heading
5/31/202306:03EDGARNotice of Effectiveness (effect)
5/16/202306:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/16/202306:06EDGARNotice of Effectiveness (effect)
5/12/202306:04EDGARCurrent Report Filing (8-k)
5/11/202316:37EDGARQuarterly Report (10-q)
5/11/202316:30GLOBEHarpoon Therapeutics Reports First Quarter 2023 Financial..
5/11/202316:10EDGARSecurities Registration Statement (simplified Form) (s-3/a)
4/27/202316:34EDGARAnnual Report to Security Holders (ars)
4/21/202317:18EDGARSecurities Registration Statement (simplified Form) (s-3)
4/18/202313:30GLOBEHarpoon Therapeutics Presents Preclinical Results for Novel..
4/17/202313:30GLOBEHarpoon Therapeutics Presents Data for New ProTriTAC™..
4/10/202316:05GLOBEHarpoon Therapeutics to Participate in the Canaccord..
4/07/202316:16EDGARSmall Company Offering and Sale of Securities Without..
4/04/202317:04EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202317:03EDGARStatement of Changes in Beneficial Ownership (4)
3/31/202316:22EDGARStatement of Ownership (sc 13g)
3/27/202317:50EDGARInitial Statement of Beneficial Ownership (3)
3/27/202316:40EDGARAnnual Report (10-k)
3/27/202316:05GLOBEHarpoon Therapeutics Reports Fourth Quarter and Full Year..
3/27/202316:02GLOBEHarpoon Therapeutics Announces Closing of $25 Million..
3/14/202318:21GLOBEHarpoon Therapeutics Announces Acceptance of Five Abstracts..
2/14/202316:47EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202307:30GLOBEHarpoon Therapeutics to Participate in the SVB Securities..
1/26/202316:08EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202316:07EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202316:06EDGARStatement of Changes in Beneficial Ownership (4)
1/18/202316:17EDGARStatement of Ownership (sc 13g)
12/12/202216:05EDGARCurrent Report Filing (8-k)
12/12/202213:03TRMNHARP Stock Doubles after Positive Phase 1 Trial Data
12/11/202210:00GLOBEHarpoon Therapeutics Presents Updated Interim Results at ASH..
12/05/202207:30GLOBEHarpoon Therapeutics to Host HPN217 Interim Results and..
12/01/202216:07EDGARCurrent Report Filing (8-k)
11/21/202216:59GLOBEHarpoon Therapeutics to Participate in the Piper Sandler..
11/16/202206:15TRMNH.C. Wainwright Keeps Their Buy Rating on Harpoon..
11/16/202202:55TRMNHarpoon Therapeutics (HARP) Receives a Buy from SVB..
11/14/202217:46EDGARCurrent Report Filing (8-k)
11/14/202216:01GLOBEHarpoon Therapeutics Updates Strategic Priorities and..
11/06/202222:35TRMNSVB Securities Sticks to Their Buy Rating for Harpoon..
11/03/202209:09GLOBEHarpoon Therapeutics to Present Interim Results from Phase 1..
10/04/202216:14EDGARStatement of Changes in Beneficial Ownership (4)
10/04/202216:10EDGARInitial Statement of Beneficial Ownership (3)
10/04/202207:30GLOBEHarpoon Therapeutics Appoints Luke Walker, M.D., as Chief..
9/19/202216:25EDGARInitial Statement of Beneficial Ownership (3)
9/19/202216:05GLOBEHarpoon Therapeutics Appoints Lauren Silvernail to Board of..
9/01/202207:30GLOBEHarpoon Therapeutics to Participate in Three Upcoming..
8/15/202206:15TRMNH.C. Wainwright Sticks to Their Buy Rating for Harpoon..
8/11/202208:35TRMNSVB Securities Reaffirms Their Buy Rating on Harpoon..
8/10/202217:11EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/10/202216:20EDGARQuarterly Report (10-q)
8/10/202216:01GLOBEHarpoon Therapeutics Reports Second Quarter 2022 Financial..